Morphine Market Report

Global Morphine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 01, 2022
  • PAGES：158
  • REPORT CODE：GMM785783
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Morphine market report explains the definition, types, applications, major countries, and major players of the Morphine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Mallinckrodt Pharmaceuticals

    • Alcaliber

    • Purdue Pharma

    • Sanofi Winthrop Industrie

    • Macfarlan Smith

    • Sun Pharmaceutical Industries

    • Qinghai Pharmaceutical

    • Northeast Pharmaceutical Group

    By Type:

    • Oral Tablets

    • Injection

    • Capsule

    • Others

    By End-User:

    • Anesthesia

    • Cough Suppressant

    • Diarrhea Suppressant

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Morphine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Morphine Outlook to 2028- Original Forecasts

    • 2.2 Morphine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Morphine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Morphine Market- Recent Developments

    • 6.1 Morphine Market News and Developments

    • 6.2 Morphine Market Deals Landscape

    7 Morphine Raw Materials and Cost Structure Analysis

    • 7.1 Morphine Key Raw Materials

    • 7.2 Morphine Price Trend of Key Raw Materials

    • 7.3 Morphine Key Suppliers of Raw Materials

    • 7.4 Morphine Market Concentration Rate of Raw Materials

    • 7.5 Morphine Cost Structure Analysis

      • 7.5.1 Morphine Raw Materials Analysis

      • 7.5.2 Morphine Labor Cost Analysis

      • 7.5.3 Morphine Manufacturing Expenses Analysis

    8 Global Morphine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Morphine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Morphine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Morphine Market Outlook by Types and Applications to 2022

    • 9.1 Global Morphine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Injection Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Capsule Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Morphine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Anesthesia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cough Suppressant Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diarrhea Suppressant Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Morphine Market Analysis and Outlook till 2022

    • 10.1 Global Morphine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Morphine Consumption (2017-2022)

      • 10.2.2 Canada Morphine Consumption (2017-2022)

      • 10.2.3 Mexico Morphine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Morphine Consumption (2017-2022)

      • 10.3.2 UK Morphine Consumption (2017-2022)

      • 10.3.3 Spain Morphine Consumption (2017-2022)

      • 10.3.4 Belgium Morphine Consumption (2017-2022)

      • 10.3.5 France Morphine Consumption (2017-2022)

      • 10.3.6 Italy Morphine Consumption (2017-2022)

      • 10.3.7 Denmark Morphine Consumption (2017-2022)

      • 10.3.8 Finland Morphine Consumption (2017-2022)

      • 10.3.9 Norway Morphine Consumption (2017-2022)

      • 10.3.10 Sweden Morphine Consumption (2017-2022)

      • 10.3.11 Poland Morphine Consumption (2017-2022)

      • 10.3.12 Russia Morphine Consumption (2017-2022)

      • 10.3.13 Turkey Morphine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Morphine Consumption (2017-2022)

      • 10.4.2 Japan Morphine Consumption (2017-2022)

      • 10.4.3 India Morphine Consumption (2017-2022)

      • 10.4.4 South Korea Morphine Consumption (2017-2022)

      • 10.4.5 Pakistan Morphine Consumption (2017-2022)

      • 10.4.6 Bangladesh Morphine Consumption (2017-2022)

      • 10.4.7 Indonesia Morphine Consumption (2017-2022)

      • 10.4.8 Thailand Morphine Consumption (2017-2022)

      • 10.4.9 Singapore Morphine Consumption (2017-2022)

      • 10.4.10 Malaysia Morphine Consumption (2017-2022)

      • 10.4.11 Philippines Morphine Consumption (2017-2022)

      • 10.4.12 Vietnam Morphine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Morphine Consumption (2017-2022)

      • 10.5.2 Colombia Morphine Consumption (2017-2022)

      • 10.5.3 Chile Morphine Consumption (2017-2022)

      • 10.5.4 Argentina Morphine Consumption (2017-2022)

      • 10.5.5 Venezuela Morphine Consumption (2017-2022)

      • 10.5.6 Peru Morphine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Morphine Consumption (2017-2022)

      • 10.5.8 Ecuador Morphine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Morphine Consumption (2017-2022)

      • 10.6.2 Kuwait Morphine Consumption (2017-2022)

      • 10.6.3 Oman Morphine Consumption (2017-2022)

      • 10.6.4 Qatar Morphine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Morphine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Morphine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Morphine Consumption (2017-2022)

      • 10.7.2 South Africa Morphine Consumption (2017-2022)

      • 10.7.3 Egypt Morphine Consumption (2017-2022)

      • 10.7.4 Algeria Morphine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Morphine Consumption (2017-2022)

      • 10.8.2 New Zealand Morphine Consumption (2017-2022)

    11 Global Morphine Competitive Analysis

    • 11.1 Mallinckrodt Pharmaceuticals

      • 11.1.1 Mallinckrodt Pharmaceuticals Company Details

      • 11.1.2 Mallinckrodt Pharmaceuticals Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Mallinckrodt Pharmaceuticals Morphine Main Business and Markets Served

      • 11.1.4 Mallinckrodt Pharmaceuticals Morphine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Alcaliber

      • 11.2.1 Alcaliber Company Details

      • 11.2.2 Alcaliber Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Alcaliber Morphine Main Business and Markets Served

      • 11.2.4 Alcaliber Morphine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Purdue Pharma

      • 11.3.1 Purdue Pharma Company Details

      • 11.3.2 Purdue Pharma Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Purdue Pharma Morphine Main Business and Markets Served

      • 11.3.4 Purdue Pharma Morphine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi Winthrop Industrie

      • 11.4.1 Sanofi Winthrop Industrie Company Details

      • 11.4.2 Sanofi Winthrop Industrie Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi Winthrop Industrie Morphine Main Business and Markets Served

      • 11.4.4 Sanofi Winthrop Industrie Morphine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Macfarlan Smith

      • 11.5.1 Macfarlan Smith Company Details

      • 11.5.2 Macfarlan Smith Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Macfarlan Smith Morphine Main Business and Markets Served

      • 11.5.4 Macfarlan Smith Morphine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sun Pharmaceutical Industries

      • 11.6.1 Sun Pharmaceutical Industries Company Details

      • 11.6.2 Sun Pharmaceutical Industries Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sun Pharmaceutical Industries Morphine Main Business and Markets Served

      • 11.6.4 Sun Pharmaceutical Industries Morphine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Qinghai Pharmaceutical

      • 11.7.1 Qinghai Pharmaceutical Company Details

      • 11.7.2 Qinghai Pharmaceutical Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Qinghai Pharmaceutical Morphine Main Business and Markets Served

      • 11.7.4 Qinghai Pharmaceutical Morphine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Northeast Pharmaceutical Group

      • 11.8.1 Northeast Pharmaceutical Group Company Details

      • 11.8.2 Northeast Pharmaceutical Group Morphine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Northeast Pharmaceutical Group Morphine Main Business and Markets Served

      • 11.8.4 Northeast Pharmaceutical Group Morphine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Morphine Market Outlook by Types and Applications to 2028

    • 12.1 Global Morphine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Capsule Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Morphine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cough Suppressant Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Diarrhea Suppressant Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Morphine Market Analysis and Outlook to 2028

    • 13.1 Global Morphine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Morphine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Morphine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Morphine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Morphine Consumption Forecast (2022-2028)

      • 13.3.2 UK Morphine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Morphine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Morphine Consumption Forecast (2022-2028)

      • 13.3.5 France Morphine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Morphine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Morphine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Morphine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Morphine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Morphine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Morphine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Morphine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Morphine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Morphine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Morphine Consumption Forecast (2022-2028)

      • 13.4.3 India Morphine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Morphine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Morphine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Morphine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Morphine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Morphine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Morphine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Morphine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Morphine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Morphine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Morphine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Morphine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Morphine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Morphine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Morphine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Morphine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Morphine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Morphine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Morphine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Morphine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Morphine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Morphine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Morphine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Morphine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Morphine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Morphine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Morphine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Morphine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Morphine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Morphine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Morphine

    • Figure of Morphine Picture

    • Table Global Morphine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Morphine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Capsule Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Anesthesia Consumption and Growth Rate (2017-2022)

    • Figure Global Cough Suppressant Consumption and Growth Rate (2017-2022)

    • Figure Global Diarrhea Suppressant Consumption and Growth Rate (2017-2022)

    • Figure Global Morphine Consumption by Country (2017-2022)

    • Table North America Morphine Consumption by Country (2017-2022)

    • Figure United States Morphine Consumption and Growth Rate (2017-2022)

    • Figure Canada Morphine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Morphine Consumption and Growth Rate (2017-2022)

    • Table Europe Morphine Consumption by Country (2017-2022)

    • Figure Germany Morphine Consumption and Growth Rate (2017-2022)

    • Figure UK Morphine Consumption and Growth Rate (2017-2022)

    • Figure Spain Morphine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Morphine Consumption and Growth Rate (2017-2022)

    • Figure France Morphine Consumption and Growth Rate (2017-2022)

    • Figure Italy Morphine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Morphine Consumption and Growth Rate (2017-2022)

    • Figure Finland Morphine Consumption and Growth Rate (2017-2022)

    • Figure Norway Morphine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Morphine Consumption and Growth Rate (2017-2022)

    • Figure Poland Morphine Consumption and Growth Rate (2017-2022)

    • Figure Russia Morphine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Morphine Consumption and Growth Rate (2017-2022)

    • Table APAC Morphine Consumption by Country (2017-2022)

    • Figure China Morphine Consumption and Growth Rate (2017-2022)

    • Figure Japan Morphine Consumption and Growth Rate (2017-2022)

    • Figure India Morphine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Morphine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Morphine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Morphine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Morphine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Morphine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Morphine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Morphine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Morphine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Morphine Consumption and Growth Rate (2017-2022)

    • Table South America Morphine Consumption by Country (2017-2022)

    • Figure Brazil Morphine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Morphine Consumption and Growth Rate (2017-2022)

    • Figure Chile Morphine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Morphine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Morphine Consumption and Growth Rate (2017-2022)

    • Figure Peru Morphine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Morphine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Morphine Consumption and Growth Rate (2017-2022)

    • Table GCC Morphine Consumption by Country (2017-2022)

    • Figure Bahrain Morphine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Morphine Consumption and Growth Rate (2017-2022)

    • Figure Oman Morphine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Morphine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Morphine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Morphine Consumption and Growth Rate (2017-2022)

    • Table Africa Morphine Consumption by Country (2017-2022)

    • Figure Nigeria Morphine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Morphine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Morphine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Morphine Consumption and Growth Rate (2017-2022)

    • Table Oceania Morphine Consumption by Country (2017-2022)

    • Figure Australia Morphine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Morphine Consumption and Growth Rate (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Company Details

    • Table Mallinckrodt Pharmaceuticals Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Morphine Main Business and Markets Served

    • Table Mallinckrodt Pharmaceuticals Morphine Product Portfolio

    • Table Alcaliber Company Details

    • Table Alcaliber Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alcaliber Morphine Main Business and Markets Served

    • Table Alcaliber Morphine Product Portfolio

    • Table Purdue Pharma Company Details

    • Table Purdue Pharma Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma Morphine Main Business and Markets Served

    • Table Purdue Pharma Morphine Product Portfolio

    • Table Sanofi Winthrop Industrie Company Details

    • Table Sanofi Winthrop Industrie Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Winthrop Industrie Morphine Main Business and Markets Served

    • Table Sanofi Winthrop Industrie Morphine Product Portfolio

    • Table Macfarlan Smith Company Details

    • Table Macfarlan Smith Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macfarlan Smith Morphine Main Business and Markets Served

    • Table Macfarlan Smith Morphine Product Portfolio

    • Table Sun Pharmaceutical Industries Company Details

    • Table Sun Pharmaceutical Industries Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Morphine Main Business and Markets Served

    • Table Sun Pharmaceutical Industries Morphine Product Portfolio

    • Table Qinghai Pharmaceutical Company Details

    • Table Qinghai Pharmaceutical Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qinghai Pharmaceutical Morphine Main Business and Markets Served

    • Table Qinghai Pharmaceutical Morphine Product Portfolio

    • Table Northeast Pharmaceutical Group Company Details

    • Table Northeast Pharmaceutical Group Morphine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Northeast Pharmaceutical Group Morphine Main Business and Markets Served

    • Table Northeast Pharmaceutical Group Morphine Product Portfolio

    • Figure Global Oral Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anesthesia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cough Suppressant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diarrhea Suppressant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Morphine Consumption Forecast by Country (2022-2028)

    • Table North America Morphine Consumption Forecast by Country (2022-2028)

    • Figure United States Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Morphine Consumption Forecast by Country (2022-2028)

    • Figure Germany Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Morphine Consumption Forecast by Country (2022-2028)

    • Figure China Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Morphine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Morphine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Morphine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Morphine Consumption Forecast by Country (2022-2028)

    • Figure Australia Morphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Morphine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US